Gladstone NOW: The Campaign Join Us on the Journey ✕
31 - 45 of 125 Results Clear All
And other questions you have about Omicron and the pandemic
Gladstone Experts COVID-19 Virology Greene Lab Ott Lab Roan Lab
In this COVID-19: Ask the Experts webinar, Gladstone virologists explain the latest science about the Omicron variant and answer questions about masking, testing, and more
Gladstone Experts COVID-19 Virology Greene Lab Ott Lab
The Atlantic—Senior Investigator Melanie Ott, MD, PhD, explains that even with additional booster shots, a vaccine directed at the original coronavirus will eventually fail to protect us from new variants.
Gladstone Experts COVID-19 Virology Ott Lab
Gladstone virologists answer your most pressing questions about the latest variant of COVID-19
Gladstone Experts COVID-19 Virology Greene Lab Ott Lab Roan Lab
Gladstone virologists discuss Omicron and what we might expect in 2022 from the COVID-19 pandemic
Gladstone Experts COVID-19 Greene Lab Ott Lab
San Francisco Chronicle—The identification of an individual infected with the Omicron variant of SARS-CoV-2 in San Francisco is helping local scientists assess the danger posed by the virus. Melanie Ott, director of the Gladstone Institute of Virology, explains that experiments using virus samples from that individual could help determine how well the available vaccines hold up to Omicron’s mutations.
Gladstone Experts COVID-19 Virology Ott Lab
Researchers at Gladstone Institutes focus on innovative strategies that could finally allow people living with HIV to stop taking daily medications
Gladstone Experts HIV/AIDS Virology Greene Lab Ott Lab Roan Lab Weinberger Lab Deep Dive
NIH Director’s Blog—The Delta variant of SARS-CoV-2 is driving the latest surge of COVID-19 cases in the United States. New research from Senior Investigators Jennifer Doudna and Melanie Ott explains how mutations in this variant increase transmissibility.
Gladstone Experts COVID-19 Virology Doudna Lab Ott Lab
Using virus-like particles, researchers find an unexpected explanation for why some coronavirus variants spread faster
Research (Publication) Data Science and Biotechnology Virology Doudna Lab Ott Lab
Gladstone virologists discuss the state of the pandemic and how to stay safe this holiday season
COVID-19 Greene Lab Ott Lab
Armed with a $26.5-million grant, a multi-institution collaboratory will tackle HIV in a new way
Grants News Release HIV/AIDS Virology Ott Lab CRISPR/Gene Editing
New analysis suggests the California variant is more transmissible than unmutated strains, but vaccines are effective against it
News Release Research (Publication) COVID-19 Virology Ott Lab
While the practice of placing papers on preprint servers ahead of peer review remains controversial in the scientific community worldwide, many Gladstone investigators are using bioRxiv to advance their research and get information out more quickly
Gladstone Experts COVID-19 Krogan Lab McDevitt Lab Ott Lab Pollard Lab
ABC7 News—Senior Investigator Melanie Ott, PhD, Director of the Gladstone Institute of Virology, talks about the long path to leadership and recognition for women in medicine.
COVID-19 Virology Ott Lab
San Francisco Business Times—Senior Investigator Melanie Ott, MD, PhD, and Graduate Student Parinaz Fozouni explain how the CRISPR- and smartphone-based diagnostic platform they recently developed with UC Berkeley Dan Fletcher, PhD, and Nobel Laureate Jennifer Doudna, PhD, could allow low-cost and widespread testing and help to quickly curb the course of this and future pandemics.
COVID-19 Virology Doudna Lab Ott Lab CRISPR/Gene Editing
